FLC Lambda is Sebia's ELISA assay for the quantification of lambda free light chains in serum - the next-generation sFLC test used with serum protein electrophoresis and immunofixation in the diagnosis and monitoring of multiple myeloma and AL amyloidosis. 96-well strip microplate.
Key Benefits
Reliable and high analytical performance results: with correct estimation of FLC values without antigen excess or overestimation by polymerization vs Nephelometry / Turbidimetry Methods.
Trust in the results: with concordance value between SPE and FLC Kappa & FLC Lambda which help on interpretation results.
Easy to implement: for patient therapy monitoring and meeting IMWG guidelines.
4 times lower retest rates: vs other methods and lower manual dilutions needed.
Easily adapted and scalable: to any type of ELISA Instrument for standardization and efficiency process.
Main Characteristics
Test Principle
Quantification of Kappa or Lambda Free Light Chains is performed with an Enzyme-Linked Immunosorbent Assay (ELISA) procedure utilizing specific antibodies anti-Kappa or anti-Lambda free light chains.
